Moody's Other Income (Expense) increased by 37.3% to -$52.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.8%, from -$42.00M to -$52.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 34.4% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$43.00M | -$57.00M | $0.00 | -$47.00M | -$65.00M | -$32.00M | -$48.00M | -$58.00M | -$48.00M | -$48.00M | -$49.00M | -$56.00M | -$35.00M | -$36.00M | -$42.00M | -$46.00M | -$50.00M | -$83.00M | -$52.00M |
| QoQ Change | — | -32.6% | +100.0% | — | -38.3% | +50.8% | -50.0% | -20.8% | +17.2% | +0.0% | -2.1% | -14.3% | +37.5% | -2.9% | -16.7% | -9.5% | -8.7% | -66.0% | +37.3% |
| YoY Change | — | — | — | — | -51.2% | +43.9% | -2.1% | +10.8% | -50.0% | — | -2.1% | +3.4% | +27.1% | +25.0% | +14.3% | +17.9% | -42.9% | -130.6% | -23.8% |